Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.

The pharmacokinetics of cinoxacin, a new antibacterial compound related to nalidixic acid and oxolinic acid, were investigated in 22 patients with varying degrees of renal impairment. After oral administration of cinoxacin at 500 mg every 12 h for 7 days to all patients, the drug was found to be wel...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Maigaard, S, Frimodt-Möller, N, Welling, P G, Madsen, P O
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1979
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352869/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/507797/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.3.411
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!